New York, November 4, 2004 – Combination therapy with Pfizer Inc's DETROL® LA (tolterodine tartrate extended release capsules) and an alpha blocker, a standard treatment for enlarged prostate, was ...

NEW YORK, August 20 - Women with mixed incontinence, a combination of overactive bladder and stress incontinence, reported a greater treatment benefit for overactive bladder symptoms from DETROL® LA ...

Tolterodine tartrate 2mg, 4mg; ext-rel caps. Swallow whole. 4mg once daily; may decrease to 2mg once daily. Concomitant strong CYP3A4 inhibitors (eg, ketoconazole, clarithromycin, ritonavir), or ...

PITTSBURGH (AP) -- Mylan Inc. said Thursday that it is now selling a generic version of Pfizer Inc.'s overactive bladder drug Detrol. The company said it started shipping its generic after receiving ...

Teva Pharmaceutical is shipping out a new product. The company announced it has launched the authorized generic form of Pfizer's Detrol LA on the U.S. market. The drug will be sold in both two ...

Pfizer and Impax Laboratories have reached an undisclosed accommodation on if and when Impax will be able to launch a generic of Pfizer's bladder-control drug Detrol LA. Detrol and the ...

WALTHAM, Mass., April 3, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's effect on ...

(Reuters) - Pfizer Inc has settled a lawsuit accusing Impax Laboratories Inc of infringing patents covering the overactive bladder drug Detrol LA. The settlement was disclosed in court papers filed in ...

NEW YORK (AP) -- Mylan Inc. plans to start selling a generic version of Pfizer Inc.'s overactive bladder drug Detrol LA in early 2014, as the two drugmakers said Friday they have resolved lawsuits ...

Global pharmaceutical company Pfizer has announced that it has settled its litigation against Mylan Pharmaceuticals relating to Pfizer’s patents covering Detrol LA (tolterodine tartrate) ...